Robert Orlowski

Merck & Co., Inc., Rahway, NJ, USA (United States)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma”.

Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0486

N/A

2.2DataRank · unranked

95 citations

Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter +20 more

Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007929

N/A

0.783DataRank · unranked

19 citations

Matthew H. Taylor, Carol Aghajanian, Allen Lee Cohn, Marcia S. Brose, Christopher Di Simone +12 more

Phase I trial of autologous cMET-directed CAR-t cells administered intravenously in patients with melanoma & breast carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10035

N/A

0.470DataRank · unranked

22 citations

Alexander C. Huang, Xiaowei Xu, Paul J. Zhang, Robert Orlowski, Tina Matlawski +15 more

Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus Pembrolizumab

The Oncologist(2021)10.1002/onco.13883

N/A

0DataRank · unranked

34 citations

Matthew H. Taylor, Ana Oaknin, Antonio Casado, Robert Orlowski, Lea Dutta +4 more

Data from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T cells Administered Intravenously in Patients with Melanoma & Breast Carcinoma

(2023)10.1158/2767-9764.c.6547846.v1

N/A

0DataRank · unranked

0 citations

Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter +20 more

Data from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma

(2023)10.1158/2767-9764.c.6547846.v2

N/A

0DataRank · unranked

0 citations

Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter +20 more